Oric Pharmaceuticals Inc. buy BiotechBee
Start price
20.01.23
/
50%
€6.20
Target price
30.04.25
€8.00
Performance (%)
-22.26%
Price
23.03.23
€4.82
Summary
This prediction is currently active. The prediction for Oric Pharmaceuticals Inc. disappoints with a performance of -22.26%. This prediction currently runs until 30.04.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Oric Pharmaceuticals Inc. | 0.417% | 0.417% |
iShares Core DAX® | 0.284% | -2.845% |
iShares Nasdaq 100 | -0.713% | 2.453% |
iShares Nikkei 225® | 0.598% | 1.320% |
iShares S&P 500 | -2.171% | -3.350% |
According to BiotechBee what are the pros and cons of Oric Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Oric Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 8,0